HOME >> MEDICINE >> NEWS
Antipsychotic drugs increase risk of death in older people with dementia

PHILADELPHIA, June 5, 2007 - A new study shows that use of antipsychotic drugs is associated with an early and sustained increase in risk of death when used to treat disruptive behavior of older adults with dementia.

The study suggests that both newer atypical antipsychotics and older conventional antipsychotics are associated with increased mortality. The highest risk appears to involve use of the older conventional drugs.

Antipsychotic drugs are approved for treating psychotic conditions such as schizophrenia and mania. But they are widely prescribed to manage behavioral symptoms of dementia, such as agitation, verbal or physical aggression and delusions, hallucinations or paranoia.

Our study adds to mounting concerns about the use of antipsychotic drugs in dementia, said Sudeep Gill, MD, MSc, a geriatric medicine specialist and the studys lead author.

The FDA and Health Canada both issued warnings in 2005 that use of newer atypical antipsychotics to treat elderly patients with dementia was associated with an increased risk of death. But Dr. Gill said, Previous trials have generally been very short and could not provide information about the long-term impact of antipsychotics on death. And relatively little information has been available on the harms associated with the older conventional or typical antipsychotics.

Investigators in the new study linked four administrative health care databases to look at health and death records of more than 27,000 people age 66 and older diagnosed with dementia between April 1, 1997, and March 31, 2002.

The investigators found:

  • Estimated mortality rate among study participants was high, especially in the long-term care setting.

  • Conventional antipsychotics were associated with higher risk for death than atypical antipsychotics, and atypical antipsychotics were associated with higher risk for death than no antipsychotic use.

'"/>

Contact: Susan Anderson
sanderson@acponline.org
215-351-2653
American College of Physicians
4-Jun-2007


Page: 1 2

Related medicine news :

1. Antipsychotic drugs increase risk of death in older people with dementia
2. Antipsychotic medications used to treat Alzheimers patients found lacking
3. Antipsychotic drug may block addiction, UIC researchers find
4. Antipsychotic treatment of dementia leads to small increase in risk of death
5. Antipsychotic drugs linked to increased risk of death for some elderly Alzheimers patients
6. UIC researchers to develop new drugs to fight bioterrorism
7. Statin drugs may delay progressive artery damage in children
8. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
9. Experts call for urgent research into anti-epileptic drugs given to children
10. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
11. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... ... 19, 2017 , ... The Semper Fi Fund, one of the nation’s highest-rated ... series of videos and a compelling documentary that provide unique insights and powerful advice ... part of its ongoing mission. , Each of the videos focuses on a specific ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... searching for solutions to their neck and back pain with a reputable physician ... Allegion Spine Institute , formerly known as Nevada Spine Clinic was founded ...
(Date:9/19/2017)... Ontario (PRWEB) , ... September 19, 2017 , ... Public ... regulation of pollutants have fallen on deaf ears, leaving the water industry itself to ... company that stays ahead of the curve in the field of natural alkaline ...
(Date:9/19/2017)... ... September 19, 2017 , ... The ISO 9001 standard sets out the ... become more efficient and improve customer satisfaction. ISO 9001:2015 was released in 2015 and ... a deadline of September 2018. , As described in this white ...
(Date:9/19/2017)... , ... September 19, 2017 ... ... and cognitive health supplement developed by a neurosurgeon, has received a big ... , Daily Brain Booster is currently available on the Wal-Mart Stores-owned ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... INDIANAPOLIS , Sept. 9, 2017  Eli Lilly ... key primary and secondary endpoint data for lasmiditan, an ... migraine, which demonstrated statistically significant improvements compared to placebo ... be highlighted today at the 18th Congress of the ... . "The data presented today demonstrate lasmiditan,s ...
(Date:9/7/2017)... Texas , Sept. 7, 2017 ... science focused on fulfilling the promise of precision ... further validate the benefits of its molecular profiling ... study utilized comprehensive genomic profiling plus (CGP+) with ... individual patient,s tumor on a molecular level, leading ...
(Date:9/7/2017)... , Sept. 7, 2017   BioLife Solutions , ... and marketer of proprietary clinical grade cell and tissue ... announces that Mike Rice , President and CEO, will ... Rodman & Renshaw 19 th Annual ... Eastern time (12:25 p.m. Pacific time). The conference is being ...
Breaking Medicine Technology:
Cached News: